Fractyl Health - Wutah pendapatan triwulanan GUTS

Fractyl Health, Inc (GUTS) - logo korporat

High R&D costs and dependence on trial outcomes create financial risks, as evidenced by the quarterly revenue growth rate. The value of 0.00 indicates the level of this metric. However, physician confidence in intestinal cell rejuvenation methods and the implementation strategy for the Revita procedure to combat obesity and diabetes minimize these threats, ensuring long-term treatment efficacy for Fractyl Health, Inc. (GUTS).

GUTS Tingkat wutah dodolan sajrone kuartal Fractyl (21.02.2024 - 20.11.2026)

Rincian metrik komprehensif lan analitis Fractyl Health Inc. (GUTS)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:Fractyl Health, Inc (GUTS)
Produk sing diprodhuksi Fractyl Health

Amidst a fierce confrontation with pharmaceutical behemoths in the diabetes and obesity treatment segment, Fractyl Health, Inc. (GUTS) is forced to fight for every share of the market. The magnitude of quarterly revenue growth, measuring the percentage change in income over a three-month cycle, clearly demonstrates the effectiveness of the company's expansion and the resilience of its cash flow, which directly determines the fair value of its capital.

Pesaing Fractyl Health, Inc. (GUTS)

ASND - Wutah pendapatan kuartal marang kuartal|MDGL: Wutah pendapatan kuartal marang kuartal|CORT: Wutah pendapatan triwulanan|RYTM - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Akero Corp|Metsera Therapeutics (MTSR) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal moonlaketx.com (MLTX)|Wutah dodolan triwulanan Crinetics Pharmaceuticals CRNX|Wutah pendapatan kuartal marang kuartal NewAmsterdam Pharma N.V. NAMS|Tingkat wutah dodolan sajrone kuartal Soleno Therapeutics Inc (SLNO)|FOLD - Wutah pendapatan kuartal marang kuartal|ETNB: Wutah pendapatan kuartal marang kuartal|AGIO: Wutah pendapatan triwulanan|Structure Therapeutics Inc. - Tambahing pendapatan triwulanan|MDXG (MiMedx Corp) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Rezolute Inc RZLT|Wutah pendapatan triwulanan LXRX|Tingkat wutah dodolan sajrone kuartal MBX Corp|Altimmune Pharma - Wutah dodolan triwulanan|Wutah pendapatan triwulanan aardvarktherapeutics.com AARD|SGMT: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan BIOA (BioAge Labs)|BMEA: Wutah pendapatan triwulanan|QNCX: Owah-owahan dodolan kuartal marang kuartal|VTVT (vTv Therapeutics Inc) - Wutah pendapatan triwulanan|Agape ATP - Dinamika pendapatan kuartal marang kuartal|Wutah dodolan triwulanan PLUR (Pluri Inc)|Tingkat wutah dodolan sajrone kuartal Synlogic Inc.|Wutah pendapatan kuartal marang kuartal Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Tingkat wutah pendapatan sajrone kuartal|Spruce Biosciences Inc. - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Wutah pendapatan kuartal marang kuartal|Lumos Pharma - Tambahing pendapatan triwulanan|ONVO (Organovo Corp) - Wutah pendapatan triwulanan|Radius Pharmaceuticals (RDUS) - Tingkat wutah dodolan sajrone kuartal